Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Their work, published in Advanced Science ("Targeted DNA Nanomachine Enables Specific miRNA-Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy"), introduces a new ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

such as for the treatment of cancer or for vaccination, require strategies to restrict replication of the virus in order to limit its toxicity 25,26. Figure 1: Using microRNA target sites to ...

In recent years, chemotherapy-induced cardiovascular disease has emerged as a significant cause of mortality among cancer survivors. Anthracyclines, pivotal in treating cancers like breast cancer and ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

This finding reinforces PROSTOX as a true measure of the biological response to radiation, independent of treatment era or technique, that can identify the safest course of [prostate cancer ...

(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers ... toxicity in patients with prostate cancer, according to a study published online April 7 in Clinical ...